Egypt Medical Device Registration Process and Timelines under EDREX GL.CAMD.002

1. Key takeaways

Under EDREX: GL.CAMD.002 Version 2, Egyptian medical device registration is split into three distinct segments, each running on its own clock. Segment one is acceptance: within 5 working days of the submission date (3 working days on the fast track), the MeDevice platform returns feedback on whether the application is accepted, rejected or suspended for correction. Segment two is assessment: within 20 working days of acceptance (7 working days on the fast track), the platform issues any requests for corrective documentation. Segment three is correction: the company must complete and upload the corrective file within 60 working days. One additional gate is easy to overlook: where an application has been suspended because the documents do not conform to the published checklist, the suspension period may last at most 90 working days, and once that window expires the application is deemed withdrawn.

2. Legal basis

3. Expert insights

Insight one: the three segments are not added end to end; the real workflow is a loop of acceptance, assessment, correction and re-assessment.

The complete chain described in workflow no.1 of the guide runs as follows: submission, then acceptance, then verification of the file against the checklist, then assessment carried out by the scientific committee, the medical device vigilance department, the stability committee and the regulatory assessment function, then issuance of a correction request, then correction by the company within 60 working days, then final review and license issuance. After the company submits its corrective file, the application returns to the assessment stage. This means the decisive variable in the total cycle is the number of correction rounds, not the arithmetic sum of the nominal time limits. When budgeting a project schedule, planning on the basis of one assessment round plus at least one correction round comes far closer to reality than quoting the headline numbers alone.

Insight two: suspension and rejection have completely different triggers, and completely different consequences.

At the acceptance stage there are three possible outcomes. The application may be accepted and passed to assessment. It may be suspended for correction because the documents do not conform to the published checklist, in which case the suspension may last up to 90 working days. Or it may be rejected, which happens where the device data in the company’s application does not match the payment receipt or the required documents, or where the application does not fall within the competence of the department concerned. Suspension is a recoverable state: after correction, the process continues on the platform under the original application number. Rejection, by contrast, terminates that application, and the company must start again.

Insight three: the most frequent cause of rejection is self-contradictory data, not technical deficiency.

The guide frames rejection around three situations: device data that does not match the payment receipt, device data that does not match the required documents, and applications submitted to the wrong competent department. In other words, the first threshold of Egyptian review is administrative consistency: the trade name, model, classification and manufacturer name must correspond verbatim across the application form, the payment receipt, the certificates and the invoices. For manufacturers from the Chinese mainland, the typical failures sit exactly here: inconsistent transliteration of the factory name, missing model suffixes, and classification wording that mixes references to the MDR with references to the MDD.

Insight four: the formal requirements for corrective documents are hard constraints, with no alternative route.

Section 4.1.3 of the guide is explicit: uploaded documents must be originals, must bear the company stamp and must be signed by the legal representative. They may be submitted as scanned uploads or by electronic signature, and the guide adds the note that no other electronic files are accepted. This differs from many markets that accept color scans or PDF exports, and it operates as a platform-level threshold in Egypt that cannot be worked around by persuasion or by follow-up correspondence.

Insight five: payment precedes acceptance and is in effect step zero of the process.

The first item of Section 4.1.1 provides that a pharmacist of the evaluation and rating department meets the representative of the registration applicant, adds the device name to the payment receipt and assigns the competent department (local or imported). Until the fees are paid and the routing is fixed, the application cannot enter the timing chain at all. Companies therefore need to treat the sequence of payment, name entry and routing assignment as a genuine front-end step when they model their timelines, rather than as a clerical formality that happens in parallel.

4. Practical recommendations

1. Build the schedule on three segments plus one correction round: do not quote or commit to customers on the basis of the nominal 5-plus-20 working days.
2. Run a full field-by-field comparison before submission: verify the trade name, model or code, classification, manufacturer name and address verbatim across the application, the payment receipt, the DoC, the FSC, the CE certificate and the invoices.
3. Decide the routing early: local manufacture and import must be distinguished at the payment stage, and choosing the wrong competent department triggers rejection outright.
4. Assemble the corrective file in one complete package: although the suspension period runs to 90 working days, the corrected file rejoins the assessment queue, and piecemeal corrections lengthen the cycle materially.
5. Prepare documents to the platform’s formal standard in advance: original, company stamp and legal representative signature are all mandatory, and scans must remain clearly legible.
6. After suspension, always continue under the original application number: the guide states that correction is completed on the platform under the number already obtained; opening a new number means rejoining the queue from the start.

5. Verification checklist

• □ Fees have been paid and the device name has been added to the receipt, with the competent department (local or imported) confirmed
• □ Acceptance feedback timing confirmed: 5 working days normal / 3 working days fast track
• □ Assessment and correction-request timing confirmed: 20 working days normal / 7 working days fast track
• □ Correction window scheduled: 60 working days for the company
• □ Suspension cap confirmed: 90 working days, after which the application is deemed withdrawn
• □ All uploaded documents meet the three requirements of original, company stamp and legal representative signature
• □ Trade name, model, classification and manufacturer fields have been cross-checked verbatim across all documents

Legal information verified as of 29 October 2026. The time limits and process nodes listed in this article follow the current text of Sections 4.1.1 to 4.1.3 of EDREX: GL.CAMD.002 Version 2; where the guide is revised or the EDA issues new announcements, the positions must be re-checked.

• Egypt local resources: GRZAN assists manufacturers from the Chinese mainland and overseas with medical device registration, import approval and change applications before the Egyptian Drug Authority (EDA), including design of the registration applicant arrangement (importing company, local factory or scientific office), preparation for scientific committee assessment, argumentation of routes for obtaining free sale certificates from reference countries, Arabic localization of labels and instructions for use, and the establishment of vigilance systems and periodic reporting.
• Service capabilities: product attribute determination and risk classification (devices Class I–III / IVD Class A–D), registration and re-registration, applicability determination for system registration and bundled registration, three-category determination of changes, import approval and annual import plans, and support for vigilance reports and field safety corrective actions.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.